Team
We are a diverse group – molecular biologists, MDs, PharmDs, tumor immunologists, stem cell biologists and computational scientists – at all career stages. We architect strategies to dissect and manipulate immune cell identity.
Members
Alumni
Cristiana Pires
Former Postdoctoral Fellow
Currently CEO at Asgard Therapeutics AB, Sweden
Rita Silvério-Alves
Former PhD Student
Currently Postdoc Fellow at Novo Nordisk Foundation, Center for Stem Cell Medicine, reNew, University of Copenhagen, Denmark
Fábio Rosa
Former PhD Student
Currently Head of Research at Asgard Therapeutics AB, Sweden
Alexandra Gabriela Ferreira
Former PhD Student
Currently Research Scientist at BioInvent International AB, Sweden
Andreia Gomes
Former PhD Student
Currently Global Product Manager HSC Engineering at Miltenyi Biotec, Portugal
Robin Scheuplein
Former MSc Student
Currently PhD student at ETH Zürich, Switzerland
Nina Lipjankić
Former MSc Student
Currently Research Associate at Acrivon AB, Sweden
Tasnim Zahan
Former MSc Student
Currently Process Development Technician at Immunicum AB, Sweden
Ariane Tenreiro
Former MSc Student
Currently PhD Student at Percy Knolle's Lab. Technical University of Munich, Germany
Svandís Sæmundsdóttir
Former Computational MSc Student
Currently Associate Consultant at Oracle, Sweden
Frederick Korbel
Former BSc Student
Currently PhD Student at Uwe Ohler Lab. Max-Delbrück-Center for Molecular Medicine, Germany
Luis Galán Palma
Former Erasmus Student
Currently Postdoc Fellow at Anna Bigas Lab. Hospital del Mar Institute, Barcelona, Spain
Collaborators
Jenny Hansson
Lund University
Proteomics. Lund, Sweden
Katharina Lahl
Lund University
Dendritic Cells. Lund, Sweden
Raquel Almeida
i3S - University of Porto
Cancer Stem Cells. Porto, Portugal
Ewa Sitnicka
Lund University
NK Cell Biology. Lund, Sweden
Johan Bengzon
Skåne University Hospital
Clinical. Neurosurgery. Lund, Sweden
Dung-Fang Lee
MD Anderson Cancer Center
Kinases and Phosphatases. Texas, U.S.A.
Kees-Jan Pronk
Skåne University Hospital
Clinical. Hematology. Lund, Sweden
Göran B Jönsson
Lund University
Melanoma. Lund, Sweden
Malin Lindstedt & Lennart Greiff
Lund University
Clinical. Head and Neck. Lund, Sweden
Cristian Bellodi
Lund University
Epitranscriptomics. Lund, Sweden
Javier Martin Gonzalez
University of Copenhagen
Transgenic Mouse Model Generation. Copenhagen, Denmark
Anna-Lena Gustavsson
SciLifeLab
Small Molecule Screening. Stockholm, Sweden
Zlatko Janeba
Czech Academy of Sciences
Medicinal Chemistry. Prague, Czech Republic
Jianwen Que
Columbia University
Lung Reprogramming. New York, U.S.A.
Inge Marie Svane
Copenhagen University Hospital
Clinical. Melanoma. Copenhagen, Denmark
Irina Agarkova
InSphero AG
Spheroids. Schlieren, Switzerland
Silvia Remeseiro
Umeå University
Chromatin Organization. Umeå, Sweden
Andreas Bender
University of Cambridge
Molecular Informatics. Cambridge, U.K.
Claudio Cantù
Linköping University
Chromatin Modification. Linköping, Sweden
Valentina Cauda
Polytechnic University of Turin
Nanoparticles. Turin, Italy
Baris Tursun
University of Hamburg
Reprograming Barriers Screening. Hamburg, Germany
Spin-Offs
Asgard Therapeutics
An important hallmark of cancer is the ability to evade the immune system. Asgard Therapeutics has the goal to establish dendritic cell reprogramming as an entirely new approach to unleash the immune system against cancer.
Blood Reprogramming Technologies
Blood Reprogramming Technologies is a biotechnology start-up focused on the use of direct cell reprogramming to generate innovative solutions for hematopoietic stem cell transplantation and blood regeneration.